Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2002
06/13/2002WO2002030906B1 Anti-tumour compounds
06/13/2002WO2002016362A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002016361A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002016360A3 Nitrogenous heterocyclic compounds
06/13/2002WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth
06/13/2002WO2001072721A3 Synergistic methods and compositions for treating cancer
06/13/2002US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma
06/13/2002US20020072521 For therapy of central nervous system disorders such as stress, anxiety, depression, cardiovascular disorders, and eating disorders
06/13/2002US20020072500 3-(carboxy(hydroxy)alkylaminocarbonylmethylaminocarbonyl), 5-(tetrahydropyrimidin-2-yl-amino)phenol for example
06/13/2002DE10061542A1 New alkanoylamino-pyrimidine derivatives used as antibacterial agents, especially for prevention and control of Staphylococcal infections
06/13/2002CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/12/2002EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods
06/12/2002EP1212301A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002EP0916639B1 Liquid crystal compounds, liquid crystal compositions containing the compounds, and liquid crystal display devices made by using the compositions
06/12/2002EP0889879B1 Butadiene derivatives and process for preparing thereof
06/12/2002EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
06/12/2002EP0817773B1 Pyrimidine compounds
06/12/2002EP0772603B1 Substituted pyrimidine compounds and their use
06/12/2002CN1353706A Integrin receptor ligands
06/12/2002CN1353697A 4-phenyl-pyrimidine derivatives
06/12/2002CN1353696A 5-phenyl-pyrimidine derivatives
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/11/2002US6403600 Fungicides.
06/11/2002US6403585 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
06/11/2002US6403580 Having an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.
06/11/2002US6403534 Uracil compounds and use thereof
06/11/2002US6403532 Herbicidal synergistic composition, and method of controlling weeds
06/11/2002US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics
06/11/2002CA2239705C Quinazoline-4-one ampa antagonists
06/06/2002WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
06/06/2002WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity
06/06/2002WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
06/06/2002WO2001093841A3 Barbituric acid analogs as therapeutic agents
06/06/2002WO2001068614A3 5-substituted arylpyrimidines
06/06/2002WO2001042225A8 4-pyrimidinyl-n-acyl-l-phenylalanines
06/06/2002US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy.
06/06/2002US20020068734 Nitrogen-containing heterocyclic compounds
06/06/2002US20020068701 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
06/06/2002US20020066888 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
06/06/2002US20020066886 Alkenyloxy substituted bi or triaromatic compounds with atleast one benzene ring
06/06/2002DE10060094A1 Preparation of 6-Amino-uracils used as stabilizer for halogenated polymers involves reacting N-(cyanoacetyl)-urea with base in matrix of plastics additives, plastics stabilizers and/or plastics
06/06/2002CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide
06/05/2002EP1211248A1 Process for the preparation of aminouraciles
06/05/2002EP1211247A1 Acylamino cyclopropane derivatives
06/05/2002EP1211246A1 Pyrimidine derivatives and herbicides containing the same
06/05/2002EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES
06/05/2002EP1210347A1 Carbocyclic nucleosides and process for obtaining such
06/05/2002EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments
06/05/2002EP1210337A1 Method for producing 4,6-dichloropyrimidine with sulfur compounds and phosphorous compounds
06/05/2002EP1079917A4 Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts
06/05/2002EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
06/05/2002EP0891336B1 Substituted 1-methyl-3-benzyluracils
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/05/2002CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV
06/05/2002CN1352637A Process for preparing MKC-442
06/05/2002CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399798 Method of preparing alkylated salicylamides
06/04/2002US6399776 Processes and intermediates in the synthesis of 5-(3-exo-bicyclo[2.2.1]hept-2-yloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-one
06/04/2002US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives
06/04/2002US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists
06/04/2002US6399603 Therapeutic heterocycles
06/04/2002US6399602 Anticancer agents
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
06/04/2002US6399290 Silver halide imaging materials
06/04/2002US6399223 Compound for use in organic EL device and organic EL device
06/04/2002CA2364108A1 Acylamino cyclopropane derivatives
05/2002
05/30/2002WO2002042280A2 Pyrimidine derivatives
05/30/2002WO2002042262A2 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002041895A1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
05/30/2002WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065271 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
05/30/2002US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives
05/30/2002CA2429570A1 Pyrimidine derivatives
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/29/2002EP1209152A1 Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alpha v beta 3 antagonism
05/29/2002EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
05/29/2002EP1208069A1 Process for catalyzing the oxidation of organic compounds
05/29/2002EP1070076A4 Chiral separations of pyrimidines
05/29/2002EP0873316B1 2-(o- pyrimidin-4-yl]methylenoxy)phenyl acetic acid derivatives and their use for controlling harmful fungi and animal pests
05/29/2002CN1351635A Reactive dye compounds
05/29/2002CN1351601A Heterocyclic compounds binding chemotactic factor receptor
05/29/2002CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
05/29/2002CN1351594A Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
05/29/2002CN1351593A Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1351585A Method of producing methoxyimino acetic amide
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1350787A Synergistic herbicidal composition and method
05/29/2002CN1350786A Synergistic herbicidal composition and method
05/29/2002CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation
05/29/2002CN1085663C Aromatic amino ethers as pain relieving agents